Paper334285
Interferons: anti-neoplastic drugs?
Strander H. Blut, 1977. Cited by 126 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Interferons: anti-neoplastic drugs? Papers, record 334285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/334285
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Interferons | Major topic |
| Animals | |
| Cell Division | |
| Fibroblasts | |
| Humans | |
| Leukocytes | |
| Neoplasm Metastasis | |
| Neoplasms | |
| Oncogenic Viruses | |
| Osteosarcoma |
Source PubMed
References98
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,601,181 | Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection. | J Infect Dis | 1974 | https://conductscience.org/library/papers/4601181 | PubMed |
| 2 | 4,620,359 | Human leukocyte interferon: production, purification, stability, and animal experiments. | In Vitro Monogr | 1974 | https://conductscience.org/library/papers/4620359 | PubMed |
| 3 | 1,144,440 | Interferon crosses blood-cerebrospinal fluid barrier in monkeys. | Proc Soc Exp Biol Med | 1975 | https://conductscience.org/library/papers/1144440 | PubMed |
| 4 | 1,168,221 | Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies. | J Immunol | 1975 | https://conductscience.org/library/papers/1168221 | PubMed |
| 5 | 53,841 | Multiple active sites on human interferons. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/53841 | PubMed |
| 6 | 5,488,061 | Interferon and cell division. II. Influence of various experimental conditions on the inhibition of L1210 cell multiplication in vitro by interferon preparations. | J Natl Cancer Inst | 1970 | https://conductscience.org/library/papers/5488061 | PubMed |
| 7 | 4,582,663 | Letter: Inhibitory effect of potent interferon preparations on the regeneration of mouse liver after partial hepatectomy. | Nature | 1973 | https://conductscience.org/library/papers/4582663 | PubMed |
| 8 | 4,546,893 | Production and purification of human leukocyte interferon. | Jpn J Microbiol | 1974 | https://conductscience.org/library/papers/4546893 | PubMed |
| 9 | 4,526,303 | The somatic cell genetics of human interferon: assignment of human interferon loci to chromosomes 2 and 5. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4526303 | PubMed |
| 10 | 60,513 | Administration of human fibroblast interferon in chronic hepatitis-B infection. | Lancet | 1976 | https://conductscience.org/library/papers/60513 | PubMed |
| 11 | 4,628,253 | Antitumor effects of interferon. | Adv Cancer Res | 1972 | https://conductscience.org/library/papers/4628253 | PubMed |
| 12 | 6,066,108 | Renal excretion of interferon. | Nature | 1967 | https://conductscience.org/library/papers/6066108 | PubMed |
| 13 | 6,165,708 | Can historical controls be used in current clinical trials in osteosarcoma. Analysis of Prognostic factors. | Int J Radiat Oncol Biol Phys | 1980 | https://conductscience.org/library/papers/6165708 | PubMed |
| 14 | 793,437 | Successful treatment of dendritic keratitis with human leukocyte interferon. A controlled clinical study. | Albrecht Von Graefes Arch Klin Exp Ophthalmol | 1976 | https://conductscience.org/library/papers/793437 | PubMed |
| 15 | 1,180,510 | Interferon. | Annu Rev Microbiol | 1975 | https://conductscience.org/library/papers/1180510 | PubMed |
| 16 | 236,313 | Heterogeneity of purified mouse interferons. | J Biol Chem | 1975 | https://conductscience.org/library/papers/236313 | PubMed |
| 17 | 265,626 | The status of interferon. | Sci Am | 1977 | https://conductscience.org/library/papers/265626 | PubMed |
| 18 | 950,957 | Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. | N Engl J Med | 1976 | https://conductscience.org/library/papers/950957 | PubMed |
| 19 | 358,466 | Anti-tumor effects of interferon and its possible use as an anti-neoplastic agent in man. | Tex Rep Biol Med | 1977 | https://conductscience.org/library/papers/358466 | PubMed |
| 20 | 14,283,276 | MECHANISM OF RECOVERY FROM VIRAL INFECTION. | Adv Virus Res | 1963 | https://conductscience.org/library/papers/14283276 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,771,762 | Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints. | Semin Immunol | 2019 | https://conductscience.org/library/papers/31771762 | PubMed |
| 18,472,817 | Cancer immunotherapy: potential involvement of mediators. | Mediators Inflamm | 1997 | https://conductscience.org/library/papers/18472817 | PubMed |
| 6,299,317 | Human lymphoblastoid interferon in the treatment of small cell lung cancer. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6299317 | PubMed |
| 6,243,928 | Interferon production and virus replication in lymphoblastoid cells infected with different viruses. | Arch Virol | 1980 | https://conductscience.org/library/papers/6243928 | PubMed |
| 6,230,183 | Immunoglobulin production by peripheral blood mononuclear cells in patients with alcoholic liver disease. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6230183 | PubMed |
| 6,178,525 | Clinical and immunological studies of human fibroblast interferon. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6178525 | PubMed |
| 6,174,540 | Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon. | J Clin Immunol | 1981 | https://conductscience.org/library/papers/6174540 | PubMed |
| 6,173,152 | Kinetics of human immune interferon production and blastogenesis. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/6173152 | PubMed |
| 6,169,305 | Interferon production by a human lymphoblastoid cell line (DG-75) free of the Epstein-Barr genome. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6169305 | PubMed |
| 6,168,641 | Effect of interferon in therapy of skin and head and neck tumors. | J Cancer Res Clin Oncol | 1981 | https://conductscience.org/library/papers/6168641 | PubMed |
| 6,160,587 | Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6160587 | PubMed |
| 6,159,047 | Does interferon cure cancer? | Br Med J | 1980 | https://conductscience.org/library/papers/6159047 | PubMed |
| 6,084,313 | Interferons, a group of multiple lymphokines. | Springer Semin Immunopathol | 1984 | https://conductscience.org/library/papers/6084313 | PubMed |
| 6,084,176 | [Interferons--research, effects and importance]. | Naturwissenschaften | 1984 | https://conductscience.org/library/papers/6084176 | PubMed |
| 3,917,376 | Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferon. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3917376 | PubMed |
| 1,690,107 | The potential of interferons in malignant disease. | Drugs | 1990 | https://conductscience.org/library/papers/1690107 | PubMed |
| 291,948 | Electrophoretically pure mouse interferon exerts multiple biologic effects. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/291948 | PubMed |
| 110,693 | Intramuscular and/or intralumbar postexposure treatment of rabies virus-infected cynomolgus monkeys with human interferon. | Infect Immun | 1979 | https://conductscience.org/library/papers/110693 | PubMed |
| 92,398 | Antiviral agents: action and clinical use. | Drugs | 1979 | https://conductscience.org/library/papers/92398 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/334285
GET https://conductscience.org/api/papers/v1/334285/references?page=2